Harry L. A. Janssen, MD, PhD, and Milan J. Sonneveld, PhD, provide detailed guidance on the appropriate candidates for hepatitis B treatment, preferred treatment options and strategies, how to manage antiviral resistance, and the appropriate choice of therapy for patients with advanced liver disease.
In this module, Jordan J. Feld, MD, MPH, and Hemant Shah, MD, MScCH HPTE, review optimal strategies for managing patients with HCV infection.
In this module, Philip N. Newsome, PhD, FRCPE, reviews key epidemiologic trends, fundamentals of the NAFL disease course, principles of diagnosis, and optimal strategies for managing patients with NAFLD and NASH.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.